| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
|
JAMA
|
2001
|
118.65
|
|
2
|
The metabolic syndrome--a new worldwide definition.
|
Lancet
|
2005
|
23.51
|
|
3
|
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
|
N Engl J Med
|
2002
|
16.23
|
|
4
|
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
|
Fertil Steril
|
2004
|
12.87
|
|
5
|
Adipose tissue as an endocrine organ.
|
J Clin Endocrinol Metab
|
2004
|
11.94
|
|
6
|
The prevalence and features of the polycystic ovary syndrome in an unselected population.
|
J Clin Endocrinol Metab
|
2004
|
7.96
|
|
7
|
Polycystic ovary syndrome.
|
N Engl J Med
|
2005
|
7.66
|
|
8
|
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
|
Circulation
|
2003
|
6.99
|
|
9
|
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.
|
Circulation
|
2000
|
6.96
|
|
10
|
Clinical assessment of body hair growth in women.
|
J Clin Endocrinol Metab
|
1961
|
6.01
|
|
11
|
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
|
Endocr Rev
|
1997
|
5.83
|
|
12
|
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.
|
J Clin Endocrinol Metab
|
2000
|
3.94
|
|
13
|
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
|
Diabetes
|
1989
|
3.74
|
|
14
|
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
|
Diabetes Care
|
1999
|
3.31
|
|
15
|
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
|
J Clin Endocrinol Metab
|
1999
|
3.24
|
|
16
|
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.
|
Am J Med
|
2001
|
2.56
|
|
17
|
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
1991
|
1.96
|
|
18
|
Low grade chronic inflammation in women with polycystic ovarian syndrome.
|
J Clin Endocrinol Metab
|
2001
|
1.89
|
|
19
|
Polycystic ovary syndrome and cardiovascular disease: a premature association?
|
Endocr Rev
|
2003
|
1.69
|
|
20
|
Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2003
|
1.61
|
|
21
|
Polycystic ovary syndrome: syndrome XX?
|
Trends Endocrinol Metab
|
2003
|
1.60
|
|
22
|
Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism.
|
J Clin Endocrinol Metab
|
1986
|
1.43
|
|
23
|
Polycystic ovary syndrome is associated with endothelial dysfunction.
|
Circulation
|
2001
|
1.34
|
|
24
|
Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women.
|
Acta Obstet Gynecol Scand
|
1992
|
1.32
|
|
25
|
Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.
|
J Clin Epidemiol
|
1998
|
1.30
|
|
26
|
Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.
|
J Clin Endocrinol Metab
|
2004
|
1.30
|
|
27
|
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
|
J Clin Endocrinol Metab
|
2006
|
1.25
|
|
28
|
The genetic basis of polycystic ovary syndrome.
|
Hum Reprod
|
1997
|
1.22
|
|
29
|
Long-term health consequences of PCOS.
|
Hum Reprod Update
|
2002
|
1.07
|
|
30
|
Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
|
J Clin Endocrinol Metab
|
2006
|
1.05
|
|
31
|
Early metabolic derangements in daughters of women with polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2007
|
1.02
|
|
32
|
American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.
|
Diabetes Care
|
2003
|
0.94
|
|
33
|
Adiponectin levels in women with polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2003
|
0.93
|
|
34
|
The genetics of polycystic ovary syndrome.
|
Am J Med
|
1995
|
0.92
|
|
35
|
Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
|
Clin Endocrinol (Oxf)
|
1996
|
0.88
|
|
36
|
Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome.
|
Endocrine
|
2006
|
0.82
|
|
37
|
Androgenetic alopecia.
|
Arch Dermatol
|
1977
|
0.75
|